← Back to Clinical Trials
Recruiting NCT07286773

NCT07286773 Biofeedback-Assisted Short Foot Exercises in Flexible Flatfoot

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07286773
Status Recruiting
Phase
Sponsor Istanbul University - Cerrahpasa
Condition Pes Planus
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-12-22
Primary Completion 2026-09-22

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
Biofeedback assisted exercisesSupervised exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-12-22 with a primary completion date of 2026-09-22.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to compare the effects of biofeedback-assisted short foot exercises and traditional short foot exercises in individuals with flexible pes planus. The study aims to determine whether adding biofeedback to short foot exercises leads to greater improvements in foot biomechanics, balance, and functional ability. The main questions it aims to answer are: Does biofeedback-assisted short foot exercise improve plantar pressure distribution and foot posture more than traditional short foot exercise? Does the use of biofeedback result in greater improvements in balance and functional ability? Researchers will compare a biofeedback-assisted short foot exercise program to a traditional short foot exercise program to evaluate their effects on plantar pressure distribution, foot posture, balance, ankle range of motion, and functional outcomes. Participants will: Be randomly assigned to either a traditional short foot exercise group or a biofeedback-assisted short foot exercise group Participate in a supervised exercise program twice per week for 6 weeks Complete pre- and post-intervention assessments, including plantar pressure analysis, balance tests, foot posture evaluation, and self-reported functional questionnaires

Eligibility Criteria

Inclusion Criteria: * Voluntary participants aged 18 to 45 years * Diagnosis of flexible pes planus * No history of surgery, fracture, or psychiatric disorder Exclusion Criteria: * Diagnosis of rigid pes planus * Age younger than 18 years or older than 45 years * History of psychiatric disorder or lower extremity trauma

Contact & Investigator

Central Contact

Taner Alparslan, Physiotherapist

✉ babaknavid@ogr.iuc.edu.tr

📞 00902128663700

Principal Investigator

Taner ALPARSLAN, PT, Master's student

PRINCIPAL INVESTIGATOR

Istanbul University - Cerrahpasa

Frequently Asked Questions

Who can join the NCT07286773 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Pes Planus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07286773 currently recruiting?

Yes, NCT07286773 is actively recruiting participants. Contact the research team at babaknavid@ogr.iuc.edu.tr for enrollment information.

Where is the NCT07286773 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07286773 clinical trial?

NCT07286773 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Taner ALPARSLAN, PT, Master's student at Istanbul University - Cerrahpasa. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology